- Home
- / ENTEROME
ENTEROME
Total Funding
$129.6 M
Revenue
€2.7 M
FY, 2020
ENTEROME Summary
Company Summary
- Overview
- Enterome is a company developing solutions in the field of diseases associated with abnormalities of the gut microbiome. It also offers a platform with biocomputational tools and bioassays to identify therapeutics from a database of full-length gut microbiome proteins.
- Type
- Private
- Status
- Active
- Founded
- 2011
- HQ
- Paris, FR | view all locations
- Website
- https://www.enterome.com/
- Cybersecurity rating
Table of Contents
Key People
Marie-Laure Bouttier, Chief Corporate Officer, Co-Founder
Christelle Dumoussaud, Chief Financial Officer
Anne Dagallier, Chief Business Officer
Operating MetricsView all
Trademarks and Trademark Applications
15
Jul, 2022
Patents and Patent Applications
87
Jul, 2022
Proteins in Database
20M
Jul, 2022
LocationsView all
2 locations detected
Paris, IDF HQ
France
94-96 Av. Ledru Rollin
Évry, Île-de-France
France
5 Rue Henri Auguste Desbruères
ENTEROME Financials
Summary Financials
- Revenue (FY, 2020)
- €2.7M
- Gross profit (FY, 2020)
- (€13.5M)
- Net income (FY, 2020)
- (€18.5M)
- Cash (FY, 2020)
- €69.4M
- EBIT (FY, 2020)
- (€22.1M)